Yingke Wu

Dr. Yingke Wu serves as Group Leader of the Nanodiamond Group at the Max Planck Institute for Polymer Research (MPIP) in Mainz, Germany, a position he assumed in 2022 after completing his doctorate at the same institution.

His academic qualifications include:

• Bachelor of Science in Polymer Materials and Engineering from Hebei University of Technology (Tianjin, China), 2014
• Master of Science in Polymer Science and Engineering from Sichuan University (Sichuan, China), 2017
• Doctorate from the Max Planck Institute for Polymer Research under Prof. Tanja Weil, 2021

Dr. Wu's research pioneers the application of nanodiamond quantum sensing technology for in-situ measurement and manipulation of intracellular parameters—including temperature, pH, and radical species—in living biological systems. His work addresses critical limitations of conventional nanoscale measurement techniques by developing sensors operable under physiological conditions, bridging quantum physics, polymer science, and medical diagnostics to solve fundamental challenges in understanding biological complexity.

Analysis of his 2021-2022 publications reveals a concentrated research trajectory advancing nanodiamond-based quantum sensing for biomedical applications, with emphasis on hydrogen peroxide detection, intracellular thermometry, and light-controlled theranostic platforms. These works demonstrate cross-disciplinary innovation spanning chemistry, materials engineering, and clinical medicine, particularly in developing real-time intracellular monitoring tools for dynamic biological processes.

Dr. Wu actively contributes to Collaborative Research Center SFB1279, which investigates the human peptidome for novel antimicrobial and anti-cancer therapeutic development.

The Nanodiamond Group operates at the forefront of quantum biotechnology, developing next-generation sensing platforms that could transform fundamental biological research and clinical diagnostics through precise nanoscale environmental monitoring in living cells.